Europe Recommends Approval for First Stem-Cell Therapy

Gen Technik 7

 

(Reuters) – European regulators have recommended approval of the first medicine containing stem cells to treat a rare condition caused by burns to the eye.

The European Medicines Agency said on Friday that Holoclar, from privately held Italian company Chiesi, had been given a green light for moderate to severe limbal stem cell deficiency due to physical or chemical burns. Left untreated, the condition can result in blindness.

READ MORE

Advertisements

Be the first to comment

Leave a Reply

Your email address will not be published.


*


This site uses Akismet to reduce spam. Learn how your comment data is processed.